Fox Business Flash top headlines are here. Check out what s clicking on FoxBusiness.com.
WASHINGTON The Federal Trade Commission is preparing to take a harder line on drug-company mergers, announcing plans Tuesday to overhaul its process for reviewing deals that could harm competition in the pharmaceutical industry.
The initiative, spurred by the FTC’s acting Democratic chairwoman, Rebecca Kelly Slaughter, signals what could be a tougher road ahead for the industry during the Biden administration. It also highlights a growing Democratic push for stronger antitrust enforcement across the economy and not just the tech sector, where a handful of companies have attracted bipartisan concern.